Exploring the Proposed Mechanism Behind Delusions and Hallucinations in Dementia-Related Psychosis
Industry Webcast Sponsored by ACADIA Pharmaceuticals Inc; Not for CME/CE Credit
March 18, 2021 | 3:40 PM - 4:25 PM ET
This program will provide general information regarding dementia-related hallucinations and delusions and will discuss a proposed neural pathway that may be associated with them. Additionally, the unmet need for the treatment of dementia-related hallucinations and delusions will be discussed, with a particular focus on the risk/benefit ratio of current atypical antipsychotics. This disease awareness, non-CME presentation is intended only for US healthcare professionals involved in the management of people with dementia-related hallucinations and delusions and is sponsored by Acadia Pharmaceuticals Inc. This program is not meant to discuss specific treatment options for dementia-related psychosis.
This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.